LLY

988.57

+2.13%↑

JNJ

225.57

+0.63%↑

ABBV

206.03

-1.03%↓

UNH

363.82

-1.87%↓

AZN

181.33

-1.06%↓

LLY

988.57

+2.13%↑

JNJ

225.57

+0.63%↑

ABBV

206.03

-1.03%↓

UNH

363.82

-1.87%↓

AZN

181.33

-1.06%↓

LLY

988.57

+2.13%↑

JNJ

225.57

+0.63%↑

ABBV

206.03

-1.03%↓

UNH

363.82

-1.87%↓

AZN

181.33

-1.06%↓

LLY

988.57

+2.13%↑

JNJ

225.57

+0.63%↑

ABBV

206.03

-1.03%↓

UNH

363.82

-1.87%↓

AZN

181.33

-1.06%↓

LLY

988.57

+2.13%↑

JNJ

225.57

+0.63%↑

ABBV

206.03

-1.03%↓

UNH

363.82

-1.87%↓

AZN

181.33

-1.06%↓

Начало・Списък с акции・Rhythm Pharmaceuticals Inc
Search

Rhythm Pharmaceuticals Inc

Затворен

СекторЗдравеопазване

81.69 0.88

Силна покупка

Обновена цена 1.05.2026 г., 19:59 ч. UTC

КупиПродай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

81.33

Максимум

82.72

Ключови измерители

By Trading Economics

Приходи

5.4M

-48M

Продажби

6M

57M

Марж на печалбата

-82.974

Служители

414

EBITDA

5.1M

-43M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+59.18% upside

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-565M

5.9B

Предишно отваряне

80.81

Предишно затваряне

81.69

Настроения в новините

By Acuity

62%

38%

312 / 347 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bearish Evidence

60 / 65.58 Подкрепа & съпротива

Rhythm Pharmaceuticals Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

5.05.2026 г., 23:43 ч. UTC

Значими събития в новините

New Zealand's Unemployment Rate Falls in 1Q

DJ

Прочетени

5.05.2026 г., 23:20 ч. UTC

Горещи акции

Stocks to Watch: AMD, Super Micro, Arista Networks, Freshworks

DJ

Прочетени

5.05.2026 г., 21:48 ч. UTC

Печалби

Suncor Energy Reports Higher 1Q Profit on Increased Oil Production

DJ

Прочетени

5.05.2026 г., 21:05 ч. UTC

Придобивния, сливания и поглъщания

Canada Antitrust Watchdog Seeks to Kibosh Keyera Deal for Plains' Canada Gas Business -- 4th Update

DJ

Прочетени

6.05.2026 г., 00:00 ч. UTC

Пазарно говорене

Canada Energy Minister Signals Energy Investments in the Pipeline -- Market Talk

DJ

Прочетени

5.05.2026 г., 23:39 ч. UTC

Пазарно говорене

Gold Rises; Trump Pauses 'Project Freedom' to See if Iran Deal Can Be Finalized -- Market Talk

DJ

Прочетени

5.05.2026 г., 22:26 ч. UTC

Пазарно говорене

AMD Data-Center Business Continues to Surge -- Market Talk

DJ

Прочетени

5.05.2026 г., 22:20 ч. UTC

Пазарно говорене

AMD's AI Revolution is Still in Early Innings, Analysts Say -- Market Talk

DJ

Прочетени

5.05.2026 г., 22:08 ч. UTC

Печалби

Correction to "Palantir Beats Forecasts" on May 4. -- WSJ

DJ

Прочетени

5.05.2026 г., 22:07 ч. UTC

Печалби

AMD Stock Soars on Strong Earnings and Growing Confidence About AI -- Barrons.com

DJ

Прочетени

5.05.2026 г., 21:48 ч. UTC

Печалби

Pan American Silver 1Q Adj EPS $1.09 >PAAS

DJ

Прочетени

5.05.2026 г., 21:48 ч. UTC

Печалби

Pan American Silver 1Q Rev $1.2B >PAAS

DJ

Прочетени

5.05.2026 г., 21:42 ч. UTC

Печалби

Arista Networks Beats Expectations, Offers Upside Guidance. The Stock Is Down. -- Barrons.com

DJ

Прочетени

5.05.2026 г., 21:38 ч. UTC

Печалби

AMD Stock Jumps on Strong Earnings and Growing Confidence About AI -- Barrons.com

DJ

Прочетени

5.05.2026 г., 21:30 ч. UTC

Печалби

Arista Networks Beats Expectations, Offers Upside Guidance. The Stock Is Down. -- Barrons.com

DJ

Прочетени

5.05.2026 г., 21:29 ч. UTC

Печалби

AMD Stock Jumps on Strong Earnings and Growing Confidence About AI -- Barrons.com

DJ

Прочетени

5.05.2026 г., 21:26 ч. UTC

Печалби

Strategy Posts Wider Loss as Bitcoin Holdings Hit $64 Billion. The Stock Falls. -- Barrons.com

DJ

Прочетени

5.05.2026 г., 21:25 ч. UTC

Печалби

Alcon Inc. 1Q EPS 39c >ALC.EB

DJ

Прочетени

5.05.2026 г., 21:25 ч. UTC

Печалби

Alcon Inc. 1Q Rev $2.71B >ALC.EB

DJ

Прочетени

5.05.2026 г., 21:24 ч. UTC

Печалби

AMD Stock Jumps on Strong Earnings and Growing Confidence About AI -- Barrons.com

DJ

Прочетени

5.05.2026 г., 21:18 ч. UTC

Печалби

Mistras Backs 2026 Rev $730M-$750M >MG

DJ

Прочетени

5.05.2026 г., 21:17 ч. UTC

Печалби

AMD Stock Jumps on Solid Earnings. AI Continues to Drive Data Center Chips. -- Barrons.com

DJ

Прочетени

5.05.2026 г., 21:15 ч. UTC

Печалби

Strategy Records Loss of Nearly $13 Billion as Bitcoin Continues Decline -- WSJ

DJ

Прочетени

5.05.2026 г., 21:12 ч. UTC

Печалби

These Stocks Are Today's Movers: Intel, PayPal, Palantir, Shopify, Micron, Duolingo, and More -- Barrons.com

DJ

Прочетени

5.05.2026 г., 21:11 ч. UTC

Печалби

SSR Mining 1Q Rev $581.8M >SSRM

DJ

Прочетени

5.05.2026 г., 21:10 ч. UTC

Печалби

SSR Mining 1Q Adj EPS $1.15 >SSRM

DJ

Прочетени

5.05.2026 г., 21:10 ч. UTC

Печалби

SSR Mining 1Q EPS $1.16 >SSRM

DJ

Прочетени

5.05.2026 г., 21:08 ч. UTC

Печалби

Arista Networks Beats Expectations, Offers Upside Guidance. The Stock Is Down. -- Barrons.com

DJ

Прочетени

5.05.2026 г., 21:01 ч. UTC

Печалби

Intact Financial 1Q EPS C$4.12 >IFC.T

DJ

Прочетени

5.05.2026 г., 21:01 ч. UTC

Горещи акции

Stocks to Watch Recap: Palantir, AMD, Intel, HSBC -- WSJ

DJ

Прочетени

Сравнение с други в отрасъла

Ценова промяна

Rhythm Pharmaceuticals Inc Прогноза

Ценова цел

By TipRanks

59.18% нагоре

12-месечна прогноза

Среден 136.23 USD  59.18%

Висок 158 USD

Нисък 105 USD

Според 14 анализатори от Wall Street, предложили 12-месечна ценова цел за Rhythm Pharmaceuticals Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

14 ratings

14

Купи

0

Задържане

0

Продай

Според 14 анализатори, дали борсови рейтинги на Rhythm Pharmaceuticals Inc през последните 3 месеца.

Техническа оценка

By Trading Central

60 / 65.58Подкрепа & съпротива

Краткосрочен план

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Средносрочен план

Bullish Evidence

All events are bullish.

Дългосрочен план

Bullish Evidence

Recent bullish events outweigh bearish events.

Настроение

By Acuity

312 / 347 Класиране в Здравеопазване

Настроения в новините

Мечи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Rhythm Pharmaceuticals Inc

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases. The company's lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is in Phase 3 clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, and other MC4R disorders. The company has licensing agreements with LG Chem, Ltd; Ipsen Pharma S.A.S; Camurus; RareStone Group Ltd.; joint research collaboration with Axovia Therapeutics for developing in bardet-biedl syndrome; and LG Chem, Ltd. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Други акции от сектора

LLY

Eli Lilly and Co.

988.57

↑ +2.13%

JNJ

Johnson and Johnson

225.57

↑ +0.63%

ABBV

AbbVie Inc

206.03

↓-1.03%

UNH

UnitedHealth Group Inc

363.82

↓-1.87%

AZN

AstraZeneca PLC

181.33

↓-1.06%
help-icon Live chat